| Literature DB >> 24838703 |
A Ludwin, I Ludwin, K Pityński, T Banas, R Jach.
Abstract
STUDY QUESTION: Can morphologic measurements (width, length and surface area) of the uterine septum predict healing-dependent abnormal anatomic results [ARs; residual septum (RS) and intrauterine adhesions in other locations (IUA-OLs)] after complete hysteroscopic metroplasty (HM)? SUMMARY ANSWER: Significant predictors of ARs are the septal width and, to a lesser extent, septal surface area. WHAT IS KNOWN ALREADY: Anatomic results after hysteroscopic metroplasty have very large variation. A RS >1 cm and IUA-OLs can aggravate reproductive outcomes, resulting in the need for reoperation. New criteria for diagnosing a uterine septum according to the European Society of Human Reproduction and Embryology (ESHRE) and European Society for Gynaecological Endoscopy (ESGE) have been suggested (ESHRE-ESGE criteria). Autocross-linked hyaluronic acid gel (autocross-linked polysaccharide) has an antiadhesive effect. STUDY DESIGN, SIZE, DURATION: A prospective, observational cohort study was performed with 96 women consecutively enrolled between 2007 and 2012. PARTICIPANTS/MATERIALS, SETTING,Entities:
Mesh:
Substances:
Year: 2014 PMID: 24838703 PMCID: PMC4059338 DOI: 10.1093/humrep/deu110
Source DB: PubMed Journal: Hum Reprod ISSN: 0268-1161 Impact factor: 6.918
Figure 1Preoperative three-dimensional sonohysterography to measure morphological parameters of the uterine septum. (A) Width. (B) Length. (C) Surface area.
Classification of anatomic results after hysteroscopic metroplasty.
| Classification | Uterine cavity shape | Intrauterine adhesions in other locations |
|---|---|---|
| ASRMa,b | ||
| Normal | Normal (internal fundal indentation/RS <1 cm) | Absent |
| Abnormalc | Abnormal (internal fundal indentation/RS ≥1 cm) | Present |
| ESHRE-ESGEb | ||
| Normal | Normal [internal fundal indentation <50% myometrial (uterine wall) thickness] | Absent |
| Abnormalc | Residual septate uterus [internal fundal indentation >50% myometrial (uterine wall) thickness] | Present |
ASRM, American Society for Reproductive Medicine; ESHRE-ESGE, European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy.
aASRM classification system and criterion of RS by length >1 cm after hysteroscopic metroplasty (Fedele ; Ludwin ).
bModified to include the presence/absence of intrauterine adhesions in other locations (Ludwin ).
cPresence the RS or adhesions in other locations or both.
Figure 2Diagnosis of RS. (A) American Society of Reproductive Medicine (ASRM) classification system with additional morphometric criterion of internal fundal indentation >1 cm (ASRM > 1 cm). (B) European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy (ESHRE-ESGE) classification system of female tract congenital anomalies and internal fundal indentation >50% myometrial (uterine wall) thickness.
Clinical parameters of patients who had hysteroscopic metroplastya.
| Parameter | Total | No antiadhesion | Autocross-linked polysaccharide | |
|---|---|---|---|---|
| Age (years) | 29 ± 5 (20–41) | 29 ± 5 (20–41) | 29 ± 5 (20–41) | 0.47 |
| Body mass index (kg/m²) | 22 [20–24] (17–38) | 23 [20–24] (18–38) | 21 [20–24] (17–34) | 0.82 |
| Procedure duration (min) | 17 [15–20] (9–41) | 17 [15–18] (9–40) | 17 [16–21] (10–41) | 0.1 |
| Medium absorption (ml) | 310 [230–400] (50–750) | 290 [230–380] (50–700) | 310 [240–400] (50–750) | 0.62 |
aN = 96 patients. Data reported as mean ± SD or median [interquartile range] (range, minimum–maximum).
Characteristics of uterine septum before, fundal myometrial thickness during metroplasty, fundal myometrial thickness and fundal notch/RS after a 6–8-week healing perioda.
| Assessment | Variable | Total | No antiadhesion | Autocross-linked polysaccharide | |
|---|---|---|---|---|---|
| No. patients | 96 | 49 | 47 | ||
| Preoperative | ASRM subclass | ||||
| VA | 19 (20%) | 9 (18%) | 10 (21%) | 0.72 | |
| VB | 77 (80%) | 40 (82%) | 37 (79%) | ||
| Width (cm) | 3.3 ± 0.8 (1.8–4.8) | 3.3 ± 0.8 (1.8–4.7) | 3.4 ± 0.8 (1.8–4.8) | 0.48 | |
| Height (cm) | 2.2 [1.9–3.2] (1.5–7.1) | 2.2 [1.9–3.2] (1.5–7.1) | 2.2 [1.9–2.5] (1.7–6.8) | 0.88 | |
| Surface area (cm2) | 4 ± 1 (1.4–7.6) | 4 ± 1 (1.4–7.6) | 4 ± 1 (1.6–7.4) | 0.57 | |
| Intraoperative after resection | Myometrial thickness (mm) | 8 ± 1 (6–10) | 8 ± 1 (6–10) | 8 ± 1 (6–10) | 0.99 |
| Follow-up | Myometrial thickness after healing (mm) | 12 ± 4 (7–24) | 13 ± 4 (7–24) | 11 ± 3 (7–18) | <0.01 |
| Length of fundal notch/RS (mm) | 4.5 [3.0–7.1] (1–15) | 4.9 [4.2–7.9] (1–15) | 3.2 [2.1–4.5] (1–8) | <0.01 |
aData reported as number (%), mean ± SD (range, minimum–maximum), or median [interquartile range] (range, minimum to maximum). Assessments: preoperative parameters assessed with three-dimensional sonohysterography; intraoperative myometrial thickness after septum resection assessed with three-dimensional transrectal ultrasonography; follow-up (6–8 weeks) myometrial thickness and RS length assessed with three-dimensional sonohysterography.
Abnormal anatomic results after complete hysteroscopic metroplastya.
| Anatomic result | Total | No antiadhesion | Autocross-linked polysaccharide | |
|---|---|---|---|---|
| No. patients | 96 | 49 | 47 | |
| Intrauterine adhesions in other locations | 9 (9%) | 7 (14%) | 2 (4%) | 0.16 |
| ASRM and morphometric criteria (RS > 1 cm) | ||||
| Residual septum | 5 (5%) | 5 (10%) | – | 0.03 |
| Abnormal anatomic result | 13 (14%) | 11 (23%) | 2 (4%) | 0.02 |
| ESHRE-ESGE criteria | ||||
| Residual septum | 19 (20%) | 16 (33%) | 3 (6%) | <0.01 |
| Abnormal anatomic result | 24 (25%) | 20 (41%) | 4 (9%) | <0.01 |
ASRM, American Society of Reproductive Medicine; ESHRE-ESGE, European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy.
aData reported as number (%). Abnormal anatomic result defined as RS or/and intrauterine adhesions in other locations.
Univariate analysis of predictors of RS and abnormal anatomic results in patients who had no adhesion barrier during hysteroscopic metroplastya and group-adjusted modelsb.
| Parameter | Criteria | Predictors | No antiadhesion | ||
|---|---|---|---|---|---|
| Odds ratio | 95% Confidence interval | ||||
| RS | ESHRE-ESGE | Width | 3.2 | 1.7–6.5 | <0.01 |
| Surface area | 1.3 | 1.0–1.8 | 0.07 | ||
| ASRM > 1 cm | Width | 9.7 | 2.4–21.0 | 0.02 | |
| Surface area | 1.8 | 1.2–3.3 | 0.02 | ||
| Group-adjusted models for RSc,d | ESHRE-ESGE | Width | 2.0 | 1.3–3.1 | <0.01 |
| Group | 0.30 | 0.14–0.60 | <0.01 | ||
| Surface area | 1.2 | 0.9–1.5 | 0.18 | ||
| Group | 0.33 | 0.16–0.63 | <0.01 | ||
| Abnormal anatomic resultse | ESHRE-ESGE | Width | 3.4 | 1.8–6.9 | <0.01 |
| Surface area | 1.4 | 1.0–1.9 | 0.04 | ||
| ASRM > 1 cm | Width | 3.1 | 1.6–6.7 | <0.01 | |
| Surface area | 1.7 | 1.2–2.6 | <0.01 | ||
| Group-adjusted models for abnormal anatomic results | ESHRE-ESGE | Width | 2.2 | 1.5–3.5 | <0.01 |
| Group | 0.26 | 0.12–0.55 | <0.01 | ||
| Surface area | 1.2 | 1.0–1.5 | 0.10 | ||
| Group | 0.31 | 0.16–0.57 | <0.01 | ||
| ASRM > 1 cm | Width | 3.5 | 1.9–7.5 | <0.01 | |
| Group | 0.22 | 0.07–0.55 | <0.01 | ||
| Surface area | 1.5 | 1.2–2.1 | <0.01 | ||
| Group | 0.32 | 0.13–0.69 | <0.01 | ||
ASRM, American Society of Reproductive Medicine; ESHRE-ESGE, European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy.
aN = 49 patients; bN = 96 patients.
cRatio between no adhesion barrier to autocross-linked polysaccharide group.
dModels adjusted by group for RS with the ASRM > 1 cm criterion could not be performed because no patient in the autocross-linked polysaccharide group had an RS > 1 cm.
eRS or/and intrauterine adhesions in other locations.
Cutoff values from receiver-operating characteristic curves in patients who had no antiadhesion prevention adhesion barrier during hysteroscopic metroplastya.
| Result | Criteria | Parameter | Cutoff | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|
| Residual septum | ESHRE/ESGE | Width (cm) | 3.4 | 81 | 73 |
| Surface area (cm²) | 3.2 | 81 | 55 | ||
| ASRM > 1 cm | Width (cm) | 3.84 | 100 | 86 | |
| Surface area (cm²) | 4.73 | 80 | 84 | ||
| Abnormal anatomic result | ESHRE/ESGE | Width (cm) | 3.42 | 80 | 79 |
| Surface area (cm²) | 3.51 | 70 | 62 | ||
| ASRM > 1 cm | Width (cm) | 3.42 | 91 | 68 | |
| Surface area (cm²) | 4.68 | 64 | 87 |
ASRM, American Society of Reproductive Medicine; ESHRE-ESGE, European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy.
aN = 49 patients.
Figure 3Receiver-operating characteristic curves of septal width and surface area to predict healing outcomes after complete hysteroscopic hysteroplasty. (A) RS. (B) Abnormal anatomic results (RS and intrauterine adhesions in other location). ASRM > 1 cm, American Society of Reproductive Medicine (ASRM) classification with additional morphometric criterion of internal fundal indentation >1 cm; ESHRE-ESHE, European Society of Human Reproduction and Embryology—European Society for Gynaecological Endoscopy classification.
Figure 4Representative uterine septa from two patients who were treated with hysteroscopic metroplasty and no antiadhesion prophylaxis. Top row (33-year-old woman): (A-1) Preoperative three-dimensional sonohysterography showing the uterine width <3.5 cm and surface area <4.5 cm2. (B-1) Myometrial thickness achieved at the completion of surgery (three- or four-dimensional transrectal ultrasonography). (C-1) After healing, RS was absent. Bottom row (30-year-old woman): (A-2) Preoperative three-dimensional sonohysterography showing uterine width >3.5 cm and surface area >4.5 cm2; the length was similar to other patient in (A-1). (B-2) Myometrial thickness achieved at the completion of surgery (three- or four-dimensional transrectal ultrasonography). A similar myometrial thickness was achieved as in other patient in (B-1). (C-2) After healing, RS was present.